Navigation Links
Aptuit Completes Sale of CTS to Catalent; Reinforces Commitment to Scientific Excellence and Most Comprehensive Early to Mid-Phase Development Capability
Date:2/17/2012

GREENWICH, Conn., Feb. 17, 2012 /PRNewswire/ -- Aptuit announces the completion of the sale of the Clinical Trials Supply business to Catalent Pharma Solutions on February 17, 2012.  Timothy C. Tyson, Chairman and CEO of Aptuit, LLC stated that Aptuit will continue to deliver scientific and service excellence to provide integrated capabilities for the early to mid phase drug development markets.

(Logo: http://photos.prnewswire.com/prnh/20120217/NY55633LOGO )

Mr. Tyson explained, "We have assembled a team comprised of some of the foremost scientific professionals in the industry. As part of our ongoing mission to engineer a better drug development process, we previously implemented a service performance initiative that drives every level of our organization. Today, Aptuit people are joining their 'heads for science' and their 'hearts for service' to continue to provide scientific excellence and a level of service that goes above and beyond what has come to be the industry standard."

Early to mid-phase services
Aptuit's early to mid-phase development services include Drug Design and Discovery, Solid State Chemistry, Preclinical Biosciences, API Development and Manufacture, Solid, Oral and Sterile Dosage Formulation, Clinical Sciences, Consulting Services and Aptuit INDiGO™, our proprietary program for fast track IND submission. Mr. Tyson noted Aptuit's best in class position in several of these key development areas, specifically citing the company's solid state chemistry, high potency API, accelerated development and lead optimization capabilities. 

Integrated or stand alone services
Stuart E. Needleman, President, Aptuit Scientific Operations, stressed that Aptuit has a team of scientific professionals in place who speak the client's language. He explained that they have extensive experience in working with multinational clie
'/>"/>

SOURCE Aptuit
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure
2. Hill-Rom Completes Acquisition of Volker
3. Positron Completes Agreement With Institute of Nuclear Research, Troitsk, Russia for Additional Strontium-82 Supply
4. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
5. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
6. Sigma-Aldrich Completes Acquisition of BioReliance
7. China Nuvo Solar Energy, Inc. Completes Name Change to SurgLine International, Inc.
8. Enlivex Completes Patient Enrollment in its Phase I/II Clinical Trial
9. ULURU Inc. Completes Altrazeal® License Agreement for Europe
10. FDA Completes Work on Three Drug User Fee Programs
11. Respironics, Inc. Completes Voluntary Recall Notification of a Limited Number of Trilogy 100 Ventilators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... methods developed to prevent and eradicate the prevalence of ... methods are confined to low specificity, safety and large ... look for a better solution. It has been discovered ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... report, "Amaranth Seed Oil Market by Extraction type (SFE, ... (Cosmetic & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & ... published by MarketsandMarkets, defines and segments the Amaranth ... of the market size in terms of value. ...
(Date:8/29/2014)... Research and Markets has announced the addition ... Pharmaceutical Equipment Market in China, 2014-2018" report to ... Forecast of Pharmaceutical Equipment Market in China ... pharmaceutical equipment industry in the aspects of current ... performance of domestic major enterprises, as well as offers ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... 26, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced ... issue of the Journal of Neuroscience a ... and National Jewish,Medical and Research Center demonstrating ... AEOL 11207, demonstrated,neuroprotection in an animal model ...
... adding Diovan to conventional therapy , , , Study ... , , BASEL,Switzerland, April 27, 2007 ... published today in The Lancet[1], show that,adding the blood ... 39% reduction in,cardiovascular events and a 40% reduction in ...
Cached Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
(Date:8/29/2014)... The Fibroids Miracle review indicates that this is a new ... and powerful results. It actually claims to be able to ... 12 hours. The method promises to lead to a permanent ... on a 3 step method that has never been revealed ... was in fact created by someone who had an important ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica ... method of naturally curing this disease. , The program ... permanent cure in only one week. This is described as ... make huge sacrifices. , Moreover, with this new method ... of sciatica in just 8 minutes. , Interested customers ...
(Date:8/29/2014)... Skmen.com, a famous online supplier of trendy clothes, has unveiled ... the moment, all these mini outfits are offered at discounted ... promotion is September 14. , The company’s senior spokesman ... our hot designs, we have listed some of the best-selling ... stylish ladies to get high quality, fashionable clothes. Many of ...
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
(Date:8/29/2014)... 2014 Developed as a nod to ... Canada Goose products offer the mobility, durability ... Arctic runways. The company’s Canada Goose Chilliwack bombers ... current market. Additionally, the firm has unveiled its new ... , At present, all high quality Chilliwack bombers are ...
Breaking Medicine News(10 mins):Health News:Fibroids Miracle Review Exposes Amanda Leto’s 3-Step Holistic System 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2
... to raise awareness of the National Marrow Donor Program , ... ... Marrow Donor Program® (NMDP) and Preston Kelly, an independent agency in ... to increase awareness of the importance of joining the Be The ...
... EHRtv on EHR implementation and the state of Healtcare IT in ... ... 24, 2009 -- EHRtv.com, the newly launched website for Comprehensive Video ... interview Former Representative Richard Gephardt during the Recent HIMSS09 Health IT ...
... Khanna institute of Lasik gives back to the community and helps ... ... Village, CA (PRWEB) April 24, 2009 -- Oaks Christian is an ... village. Recently, The Khanna Institute supported their efforts and ...
... in the Lungs , A group led by Dr. ... as a mediator of lung fibrosis. They present their data in ... . , Scar tissue, or fibrosis, can accumulate in ... lung disease, respiratory failure, and eventually death. An increase in ...
... World Malaria Day Events Held in Nairobi , ... Washington LAUSANNE, Switzerland, ... on 4/25, ,Counting Malaria Out, Vestergaard Frandsen is stepping up ... a new version that is effective against insecticide resistant mosquitoes. Malaria ...
... might be replicated for heart disease, scientists say, , , THURSDAY, ... patient,s own skin cells to grow tissue-engineered shunts for dialysis ... The problem right now is that about half of all ... via a plastic tube that creates a shunt -- a ...
Cached Medicine News:Health News:Be The MatchSM Brand Campaign Launches 2Health News:Be The MatchSM Brand Campaign Launches 3Health News:Representative Richard Gephardt Sits Down With EHRtv.com 2Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Tips from the American Journal of Pathology 2Health News:Tips from the American Journal of Pathology 3Health News:Tips from the American Journal of Pathology 4Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 2Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 4
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
The HT-PB is a implantable bipolar tined permanent pacing lead for stimulation of the ventricle....
Medicine Products: